ZBIOZenas BioPharma, Inc.
$26.87+11% 1Y
$26.87
$15.2052 weeks$43.17
Is it growing?
Watch
1 to watch, 2 without dataRevenue shrinking (−93% year on year). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Revenue trend−93% in a yearSEC EDGAR · Jun 30, 2026
Trailing-twelve-month revenue vs a year earlier, from the company's own filings.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is ZBIO growing?
- Years of annual history on file
- 3
Years of annual history on file · FY2023 to FY2025, as filed
Details›
- Revenue FY2023
- $50M
- Revenue FY2024
- $5.0M
- Revenue FY2025
- $10M
Annual income statements as filed with the SEC.
On our screens:Most shorted stocks
Biotechnology
The closest names by size in the same industry